Second primary lung malignancy following head and neck squamous cell carcinoma

Area of Science:

• Oncology
• Pulmonology
• Epidemiology

Background:

• Head and neck squamous cell carcinoma (HNSCC) is a significant health concern.
• Understanding the risk and characteristics of subsequent malignancies is crucial for patient management.
• Second primary lung malignancies (SPLMs) represent a notable complication in HNSCC survivors.

Purpose of the Study:

• To analyze the characteristics of second primary lung malignancies (SPLMs) that arise after an initial diagnosis of head and neck squamous cell carcinoma (HNSCC).
• To determine the relative risk of developing lung cancer in HNSCC patients compared to the general population.
• To compare the histopathological features of SPLMs with other lung cancers and investigate subsite-specific risks.

Main Methods:

• Retrospective cohort study utilizing the Surveillance, Epidemiology and End Results (SEER) database (1973-2014).
• Compared HNSCC patients (N=101,856) to a standard population for lung cancer risk (Standardized Incidence Ratio - SIR).
• Analyzed histopathological differences between SPLMs (N=8,116) and all other lung cancers (N=1,160,853).

Main Results:

• 8.0% of HNSCC patients developed SPLMs (SIR=4.22, P<.001), with a mean diagnosis interval of 6.7 years.
• Highest risks for SPLMs were observed in patients with HNSCC of the supraglottis (SIR=8.10) and hypopharynx (SIR=6.34).
• SPLMs were significantly more likely to be squamous cell carcinoma (42.0% vs. 21.0%, P<.001) compared to other lung cancers.

Conclusions:

• HNSCC patients treated with curative intent face a high risk of developing SPLMs.
• Subsite-specific risk variations may offer insights into etiological factors like smoking, genetics, HPV, or metastatic disease.
• Further research into these factors can refine risk stratification and management strategies for HNSCC survivors.